NeoGenomics
+$0.11 (+0.26%) Today
+$0.10 (+0.24%) As of 9:49 AM UTC after-hours
Why Robinhood?
You can buy or sell NeoGenomics and other stocks, options, and ETFs commission-free!
About NEO
NeoGenomics, Inc. Common Stock, also called NeoGenomics, is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services.
CEO
Mark Mallon
Employees
1,700
Headquarters
Fort Myers, Florida
Founded
1998
NEO Key Statistics
Market Cap
5.58B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
879.86K
High Today
$42.12
Low Today
$39.75
Open Price
$41.30
Volume
1.90M
52 Week High
$61.57
52 Week Low
$25.19
Analyst Ratings
92%
of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%
NEO Earnings
-$0.14
-$0.01
$0.12
$0.25
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available May 13, Pre-Market